The emerging approach of the medication represents a exciting breakthrough in the handling of diabetes mellitus type 2. Unlike existing medications, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatide-peptide901326.aioblogs.com/94738948/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment